Rchr
J-GLOBAL ID：200901010536802561
Update date: Jul. 15, 2024
Hasebe Yuki
ハセベ ユキ | Hasebe Yuki
Affiliation and department：
Job title：
Assistant Professor
Research field (1)：
Tumor biology
Research keywords (3)：
末梢血循環癌細胞
, 薬剤耐性
, 遺伝子治療
Research theme for competitive and other funds (1)：
- 2023 - 2026 非小細胞性肺癌における末梢血循環癌細胞(CTC)新規同定法の開発
Papers (14)：
-
Yuki Hasebe, Michio Naoe. Gamma-delta T cells are optimal immune cell carrier vehicles for adenovirus vector-based gene therapy. The Showa University Journal of Medical Sciences. 2023. 35. 3. 103-111
-
Shigetoshi Nishihara, Toshimitsu Yamaoka, Fumihiro Ishikawa, Kensuke Higuchi, Yuki Hasebe, Ryo Manabe, Yasunari Kishino, Sojiro Kusumoto, Koichi Ando, Yusuke Kuroda, et al. Mechanisms of EGFR-TKI-Induced Apoptosis and Strategies Targeting Apoptosis in EGFR-Mutated Non-Small Cell Lung Cancer. Genes. 2022. 13. 12
-
Shigetoshi Nishihara, Toshimitsu Yamaoka, Fumihiro Ishikawa, Tohru Ohmori, Koichi Ando, Sojiro Kusumoto, Yasunari Kishino, Ryo Manabe, Yuki Hasebe, Hironori Sagara, et al. Diverse Mechanisms of Resistance against Osimertinib, a Third-Generation EGFR-TKI, in Lung Adenocarcinoma Cells with an EGFR-Activating Mutation. Cells. 2022. 11. 14
-
Takehiko Nakasato, Chiho Kusaka, Mika Ota, Yuki Hasebe, Kumiko Ueda, Tsutomu Unoki, Kazuhiko Oshinomi, Jun Morita, Yoshiko Maeda, Takeshi Shichijo, et al. A Novel, Circulating Tumor Cell Enrichment Method Reduces ARv7 False Positivity in Patients with Castration-Resistant Prostate Cancer. Diagnostics (Basel, Switzerland). 2020. 10. 3
-
Michio Naoe, Chiho Kusaka, Mika Ohta, Yuki Hasebe, Tsutomu Unoki, Hideaki Shimoyama, Takehiko Nakasato, Kazuhiko Oshinomi, Jun Morita, Kohzo Fuji, et al. Development of a Highly Sensitive Technique for Capturing Renal Cell Cancer Circulating Tumor Cells. Diagnostics (Basel, Switzerland). 2019. 9. 3
ｍore...
MISC (25)：
-
山岡 利光, 長谷部 友紀, 眞鍋 亮, 岸野 康成, 楠本 壮二郎, 安藤 浩一, 大森 亨, 相良 博典, 鶴谷 純司. 肺腺癌細胞PC-9におけるオシメルチニブの獲得耐性機序の検討. 肺癌. 2022. 62. 6. 753-753
-
西原 成俊, 山岡 利光, 長谷部 友紀, 石川 文博, 楠本 壮二郎, 大森 亨, 相良 博典, 吉田 仁, 鶴谷 純司. 肺腺癌細胞における第3世代EGFR-TKIオシメルチニブの獲得耐性機序の検討(Resistance mechanisms against osimertinib in lung adenocarcinoma cells with EGFR-activating mutation). 日本癌学会総会記事. 2022. 81回. P-2365
-
直江道夫, 太田実香, 長谷部友紀, 松井祐輝, 鵜木勉, 下山英明, 中里武彦, 小川良雄, 塚田愛, 砂川正隆, et al. CTC(末梢血循環癌細胞)同定法と泌尿器科癌領域におけるCTC検査の重要性. 泌尿器外科. 2018. 31. 臨増. 591-595-595
-
直江 道夫, 下山 英明, 中里 武彦, 長谷部 友紀, 辻山 和子, 小川 良雄, 石毛 真行, 大澤 宏典, 松崎 正晴, 服部 徹, et al. 泌尿器科癌領域におけるCTC(末梢血循環癌細胞)検査. 西日本泌尿器科. 2017. 79. 10. 441-448
-
Nakasato Takehiko, Naoe Michio, Hasebe Yuki, Tujiyama Kazuko, Matui Yuki, Oshinomi Kazuhiko, Morita Jun, Sichijo Takeshi, Maeda Yoshiko, Fuji Kohzo, et al. 検出率向上、定量的評価、AR-V7陽性細胞の観点からの前立腺癌における新規循環腫瘍細胞評価法(New circulating tumor cells evaluation method in prostate cancer from the points of detection rate improvement, quantitative evaluation and AR-V7-positive cells). 日本泌尿器科学会総会. 2017. 105回. JUA-1
ｍore...
Patents (1)：
Lectures and oral presentations (1)：
-
肺腺癌細胞PC-9におけるオシメルチニブの獲得耐性機序の検討
(第69回昭和大学学士会総会 2022)
Professional career (1)：
Association Membership(s) (1)：
Return to Previous Page
